Scientists unshelve a decades-old antibiotic to fight ovarian cancer – STAT
The results are preliminary, but convincing enough that researchers are moving ahead with a Phase 1 clinical trial in ovarian cancer.
The results are preliminary, but convincing enough that researchers are moving ahead with a Phase 1 clinical trial in ovarian cancer.
A tiny shred of data on Amgen’s lead obesity candidate — not yet verified — erased $12 billion in market value on Tuesday
A new Trump administration “opens avenues of creativity” for the health policy world, says @CarmelShachar on the “First Opinion Podcast.”
After watching a pulse oximeter struggle with his father’s dark skin, @AmBeRnIgAm began a personal quest to confront racial bias in medical generative AI.
During chief executive Mike Mahoney’s 12-year tenure, Boston Scientific has completed more than 40 acquisitions.
Advances are helping people born with heart defects to make it into adulthood and retirement age. Medical care hasn’t kept up.
Experts worry RFK could put out misinformation on the effects of fluoride that would harm public health.
Johnson & Johnson has sued a U.S. government agency over a closely watched dispute focusing on payment methods for some hospitals that participate in
The Department of Justice sued to prevent UnitedHealth Group from buying Amedisys, one of the largest home health and hospice chains
Narcotics Anonymous and Salvation Army are often hostile to use of the addiction medications buprenorphine and methadone.
You’re reading the web version of Health Care Inc., STAT’s weekly newsletter following the flow of money in medicine. Sign up to get it in your inbox